Papapoulos, Socrates E.

Atypical subtrochanteric and diaphyseal femoral fractures: Second report of a task force of the American Society for Bone and Mineral Research

Shane, E., Burr, D., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., Dempster, D. W., et al. (2014) · Journal of Bone and Mineral Research

Bone health and osteoporosis researchBone health and treatments

Cited by 2,147

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

Shane, E., Burr, D., Ebeling, P. R., Abrahamsen, B., Adler, R. A., Brown, T. D., Cheung, A. M., Cosman, F., Curtis, J. R., Dell, R., et al. (2010) · Journal of Bone and Mineral Research

Bone health and osteoporosis researchBone health and treatments

Cited by 1,116

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension

Bone, H. G., Wagman, R. B., Brandi, M. L., Brown, J. P., Chapurlat, R., Cummings, S. R., Czerwiński, E., Fahrleitner-Pammer, A., Kendler, D. L., Lippuner, K., et al. (2017) · The Lancet Diabetes & Endocrinology

Bone health and osteoporosis researchBone health and treatments

Cited by 996

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Poole, K. E. S., Van Bezooijen, R. L., Loveridge, N., Hamersma, H., Papapoulos, S. E., Löwik, C. W., & Reeve, J. (2005) · The FASEB Journal

Bone Metabolism and DiseasesBone health and osteoporosis research

Cited by 965

Atypical fractures of the femur and bisphosphonate therapy

Giusti, A., Hamdy, N. A. T., & Papapoulos, S. E. (2010) · Bone

Bone health and osteoporosis researchBone health and treatments

Cited by 295

Prolonged bisphosphonate release after treatment in children

Papapoulos, S. E., & Cremers, S. C. L. M. (2007) · New England Journal of Medicine

Bone health and osteoporosis researchBone health and treatments

Cited by 210

Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

McClung, M. R., O'Donoghue, M. L., Papapoulos, S. E., Bone, H., Langdahl, B., Saag, K. G., Reid, I. R., Kiel, D. P., Cavallari, I., Bonaca, M. P., et al. (2019) · The Lancet Diabetes & Endocrinology

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 169

Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®

Hans, D. B., Kanis, J. A., Baim, S., Bilezikian, J. P., Binkley, N., Cauley, J. A., Compston, J. E., Cooper, C., Dawson-Hughes, B., El-Hajj Fuleihan, G., et al. (2011) · Journal of Clinical Densitometry

Bone health and osteoporosis researchHip and Femur Fractures

Cited by 91